According to Harvard Bioscience's latest financial reports the company's current earnings are C$97.73 Million. In 2023 the company made an earning of -C$3.65 Million, an increase over its 2022 earnings that were of -C$13.1 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -C$18.1 Million | 396.09% |
2023 | -C$3.65 Million | -72.15% |
2022 | -C$13.1 Million | 6456.43% |
2021 | -C$0.2 Million | -98.08% |
2020 | -C$10.41 Million | 32.53% |
2019 | -C$7.86 Million | -31.01% |
2018 | -C$11.38 Million | 243.9% |
2017 | -C$3.31 Million | -24.66% |
2016 | -C$4.4 Million | -14.69% |
2015 | -C$5.15 Million | -181.68% |
2014 | C$6.3 M | -9.97% |
2013 | C$7 M | 120% |
2012 | C$3.18 M | -50.9% |
2011 | C$6.48 M | -52.51% |
2010 | C$13.64 M | -2.53% |
2009 | C$14 M | 28.26% |
2008 | C$10.91 M | -20.05% |
2007 | C$13.65 M | 13.96% |
2006 | C$11.98 M | 17.59% |
2005 | C$10.18 M | 57.37% |
2004 | C$6.47 M | -37.31% |
2003 | C$10.32 M | 208.03% |
2002 | C$3.35 M | -168.71% |
2001 | -C$4.88 Million | -66.89% |
2000 | -C$14.74 Million |